H1 Blog

JUNE 7, 2023

Clinical trial success is a key factor for pharma companies when designing and recruiting patients into trials. This data can also provide guidance in terms of diversifying clinical trials to include different types of population demographics such as age, gender, race, ethnicity, or geographic location.

Trials 52

Trials Clinical Trials Pharma Companies Clinical Development 52

H1 Blog

JULY 30, 2024

Increasing diversity in clinical trials not only makes the findings more relevant to various patient groups, but also enhances knowledge about the disease or medical product being studied. We’re curious to see what will happen over the next 12 months and how pharma companies will respond.”

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

H1 Blog

JULY 5, 2023

The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market. African Americans).

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52